[Immunological study of alopecia areata]. 1980

B Wüthrich, and P J Grob, and S Zisiadis

Sixteen patients with varying degrees of alopecia areata, without an associated disease were examined before and during a local DNCB therapy for evidence of immunological abnormalities in both cellular and humoral immune parameters. The mean values of IgG, IgA, IgM, IgE, complement factors C3 and C4 and of alpha 1-antitrypsin were found within the norm, of the C1-Inhibitor slight diminished. Antinuclear antibodies in low titer were observed in three, antithyroglobulin antibodies in two young patients. Immuncomplexes were always negative. The mean value for T cells (67 +/- 7%) was normal as well as the lymphocyte transformation to phytohemagglutin, pokweed-mitogen and candidin, the PPD stimulation was slight reduced. No changes in the immunprofile were observed during the DNCB therapy, with exception of a slight, but significant increase of the T cell number from 63 +/- 8% to 77 +/- 5%. Our findings exclude a common systemic immune defect in alopecia areata.

UI MeSH Term Description Entries
D007136 Immunoglobulins Multi-subunit proteins which function in IMMUNITY. They are produced by B LYMPHOCYTES from the IMMUNOGLOBULIN GENES. They are comprised of two heavy (IMMUNOGLOBULIN HEAVY CHAINS) and two light chains (IMMUNOGLOBULIN LIGHT CHAINS) with additional ancillary polypeptide chains depending on their isoforms. The variety of isoforms include monomeric or polymeric forms, and transmembrane forms (B-CELL ANTIGEN RECEPTORS) or secreted forms (ANTIBODIES). They are divided by the amino acid sequence of their heavy chains into five classes (IMMUNOGLOBULIN A; IMMUNOGLOBULIN D; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M) and various subclasses. Globulins, Immune,Immune Globulin,Immune Globulins,Immunoglobulin,Globulin, Immune
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D003174 Complement C1 Inactivator Proteins Serum proteins that inhibit, antagonize, or inactivate COMPLEMENT C1 or its subunits. Complement 1 Esterase Inhibitors,Complement C1 Inactivating Proteins,Complement C1 Inhibiting Proteins,Complement C1 Inhibitor Proteins,Complement C1r Protease Inhibitor Proteins,Complement C1s Esterase Inhibitor Proteins,Complement Component 1 Inactivator Proteins
D003176 Complement C3 A glycoprotein that is central in both the classical and the alternative pathway of COMPLEMENT ACTIVATION. C3 can be cleaved into COMPLEMENT C3A and COMPLEMENT C3B, spontaneously at low level or by C3 CONVERTASE at high level. The smaller fragment C3a is an ANAPHYLATOXIN and mediator of local inflammatory process. The larger fragment C3b binds with C3 convertase to form C5 convertase. C3 Complement,C3 Precursor,Complement 3,Complement C3 Precursor,Complement Component 3,Precursor-Complement 3,Pro-C3,Pro-Complement 3,C3 Precursor, Complement,C3, Complement,Complement, C3,Component 3, Complement,Precursor Complement 3,Precursor, C3,Precursor, Complement C3,Pro C3,Pro Complement 3
D003181 Complement C4 A glycoprotein that is important in the activation of CLASSICAL COMPLEMENT PATHWAY. C4 is cleaved by the activated COMPLEMENT C1S into COMPLEMENT C4A and COMPLEMENT C4B. C4 Complement,C4 Complement Component,Complement 4,Complement C4, Precursor,Complement Component 4,Pro-C4,Pro-complement 4,C4, Complement,Complement Component, C4,Complement, C4,Component 4, Complement,Component, C4 Complement,Pro C4,Pro complement 4
D004137 Dinitrochlorobenzene A skin irritant that may cause dermatitis of both primary and allergic types. Contact sensitization with DNCB has been used as a measure of cellular immunity. DNCB is also used as a reagent for the detection and determination of pyridine compounds. 1-Chloro-2,4-Dinitrobenzene,2,4-Dinitrochlorobenzene,Benzene, 1-Chloro-2,4-Dinitro-,Chlorodinitrobenzene,DNCB,1 Chloro 2,4 Dinitrobenzene,2,4 Dinitrochlorobenzene
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

B Wüthrich, and P J Grob, and S Zisiadis
January 1983, Vestnik dermatologii i venerologii,
B Wüthrich, and P J Grob, and S Zisiadis
February 1984, The British journal of dermatology,
B Wüthrich, and P J Grob, and S Zisiadis
March 1987, Nederlands tijdschrift voor geneeskunde,
B Wüthrich, and P J Grob, and S Zisiadis
January 1990, Przeglad dermatologiczny,
B Wüthrich, and P J Grob, and S Zisiadis
January 1985, Acta Universitatis Carolinae. Medica,
B Wüthrich, and P J Grob, and S Zisiadis
January 1979, International archives of allergy and applied immunology,
B Wüthrich, and P J Grob, and S Zisiadis
March 2021, International journal of molecular sciences,
B Wüthrich, and P J Grob, and S Zisiadis
December 1950, British medical journal,
B Wüthrich, and P J Grob, and S Zisiadis
January 1984, Dermatologica,
B Wüthrich, and P J Grob, and S Zisiadis
October 2004, Dermatology online journal,
Copied contents to your clipboard!